Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica

Infection and Immunity

Volumn 76, Issue 5, 2008, Pages 2157-2163

  Zhao, Zhanqin ^a   Xue, Yun ^a   Wu, Bin ^a   Tang, Xibiao ^a   Hu, Ruiming ^a   Xu, Yindi ^a   Guo, Aizhen ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PHOSPHATE BUFFERED SALINE; SALMONELLA ENTERICA SEROVAR CHOLERAESUIS C500; SALMONELLA ENTERICA SEROVAR CHOLERAESUIS C501; SALMONELLOSIS VACCINE; ADHESIN; BACTERIUM ANTIBODY; BORDETELLA VIRULENCE FACTOR; FILAMENTOUS HEMAGGLUTININ ADHESIN, BORDETELLA PERTUSSIS; OUTER MEMBRANE PROTEIN; PERTACTIN; PERTUSSIS VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BORDETELLA BRONCHISEPTICA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNOGENICITY; LOBAR PNEUMONIA; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SEROTYPE; VACCINATION; ANIMAL; ANIMAL SALMONELLOSIS; BACTERIAL COUNT; BAGG ALBINO MOUSE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; LUNG; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PEYER PATCH; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL;

ADHESINS, BACTERIAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; COLONY COUNT, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; LUNG; MICE; MICE, INBRED BALB C; PERTUSSIS VACCINE; PEYER'S PATCHES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA VACCINES; SURVIVAL ANALYSIS; VIRULENCE FACTORS, BORDETELLA;

EID: 42949175209     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01495-07     Document Type: Article

References (36)

1. Backstrom, L. 1999. Present uses of and experiences with swine vaccines. Adv. Vet. Med. 41:419-428.
2. Baysinger, A. 1999. PRDC: is it new or déjà vu? Pork '99 19:64.
3. Bertani, G. 1952. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293-300.
4. Charles, I. G., J. Li, M. Roberts, K. Beesley, M. Romanos, D. J. Pickard, M. Francis, D. Campbell, G. Dougan, M. J. Brennan, C. R. Manclark, M. Au Jensen, I. Heron, A. Chubb, P. Novotny, and N. F. Fairweather. 1991. Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussis. Eur. J. Immunol. 21: 1147-1153.
5. r) BALB/c mice. Infect. Immun. 67:2025-2029.
6. De Jong, M. F. 1999. Progressive and nonprogressive atrophic rhinitis, p. 355-384. In B. E. Straw, S. d'Allaire, W. L. Mengeling, and D. J. Taylor (ed.), Diseases of swine. Iowa State University Press, Ames.
7. DiGiandomenico, A., J. Rao, K. Harcher, T. S. Zaidi, J. Gardner, A. N. Neely, G. B. Pier, and J. B. Goldberg. 2007. Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. USA 104:4624-4629.
8. Di Tommaso, A., M. Domenighini, M. Bugnoli, A. Tagliabue, R. Rappuoli, and M. T. De Magistris. 1991. Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses. Infect. Immun. 59:3313-3315.
9. Edwards, R. A., L. H. Keller, and D. M. Schifferli. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149-157.
10. Fang, X., Y. Li, C. Huang, M. Zheng, W. Feng, and W. Sun. 1981. Live vaccine against swine paratyphoid from the attenuated smooth strain C500 of Salmonella choleraesuis. Chin. J. Anim. Vet. Sci. 2:99-106.
11. Gálan, J. E., K. Nakayama, and R. Curtiss III. 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94:29-35.
12. Gay, P., D. Le Coq, M. Steinmetz, T. Berkelman, and C. I. Kado. 1985. Positive selection procedure for entrapment of insertion sequence elements in gram-negative bacteria. J. Bacteriol. 164:918-921.
13. Heritage, P. L., B. J. Underdown, A. L. Arsenault, D. P. Snider, and M. R. McDermott. 1997. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am. J. Respir. Crit. Care Med. 156:1256-1262.
14. Hopkins, S., J. P. Kraehenbuhl, F. Schodel, A. Potts, D. Peterson, P. De Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
15. Huang, C., W. Feng, M. Xue, X. Zhang, S. Yang, S. Yang, Y. Dou, and S. Jia. 1981. Oral administration of the live vaccine against swine paratyphoid. Sci. Agric. Sin. 6:89-94.
16. Huang, H., R. Zhou, H. Fan, H. Dan, M. Chen, L. Yan, W. Bei, and H. Chen. 2006. Generation of monoclonal antibodies and epitope mapping of ApxIVA of Actinobacillus pleuropneumoniae. Mol. Immunol. 43:2130-2134.
17. Kang, H. Y., J. Srinivasan, and R. Curtiss III. 2002. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect. Immun. 70:1739-1749.
18. Knight, J. B., Y. Y. Huang, S. A. Halperin, R. Anderson, A. Morris, A. Macmillan, T. Jones, D. S. Burt, G. Van Nest, and S. F. Lee. 2006. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis. Clin. Exp. Immunol. 144:543-551.
19. Kobisch, M., and P. Novotny. 1990. Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets. Infect. Immun. 58:352-357.
20. Leininger, E., S. Bowen, G. Renauld-Mongenie, J. H. Rouse, F. D. Menozzi, C. Locht, I. Heron, and M. J. Brennan. 1997. Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J. Infect. Dis. 175:1423-1431.
21. Menozzi, F. D., P. E. Boucher, G. Riveau, C. Gantiez, and C. Locht. 1994. Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect. Immun. 62:4261-4269.
22. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction on insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
23. Ministry of Agriculture of the People's Republic of China. 2000. The People's Republic of China veterinary biological product regulation, p. 164-166. Chemical Industry Publishing Company, Beijing, China.
24. Montaraz, J. A., P. Novotny, and J. Ivanyi. 1985. Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Infect. Immun. 47:744-751.
25. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 6:693-697.
26. Novotny, P., M. Kobisch, K. Cownley, A. P. Chubb, and J. A. Montaraz. 1985. Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect. Immun. 50:190-198.
27. Ohgitani, T., T. Okabe, and N. Sasaki. 1991. Characterization of haemagglutinin from Bordetella bronchiseptica. Vaccine 9:653-658.
28. Piatti, G. 1999. Identification of immunodominant epitopes in the filamentous hemagglutinin of Bordetella pertussis. FEMS Immunol. Med. Microbiol. 23:235-241.
29. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
30. Sakurai, Y., H. Suzuki, and E. Terada. 1993. Purification and characterisation of haemagglutinin from Bordetella bronchiseptica. J. Med. Microbiol. 39:388-392.
31. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Sirard, J. C., F. Niedergang, and J. P. Kraehenbuhl. 1999. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol. Rev. 171:5-26.
33. Spreng, S., G. Dietrich, and G. Weidinger. 2006. Rational design of Salmonella-based vaccination strategies. Methods 38:133-143.
34. U.S. Department of Agriculture. 2002. Part II: reference of swine health and health management in the United States, 2000. No. N355.0202:2002:29. National Animal Health Monitoring System, Fort Collins, CO.
35. phox-/- mice. Infect. Immun. 70:2614-2621.
36. Wilson, D. R., A. Siebers, and B. B. Finlay. 1998. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies. Infect. Immun. 66:4884-4894.